Previous Article | Next Article 
Journal of Virology, July 2000, p. 6408-6417, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Human Papillomavirus Type 16 E6 Induces
Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase
Wynn H.
Kao,1
Sylvie L.
Beaudenon,2
Andrea L.
Talis,1
Jon M.
Huibregtse,2,* and
Peter M.
Howley1,*
Department of Pathology, Harvard Medical
School, Boston, Massachusetts 02115,1 and
Department of Molecular Biology and Biochemistry, Rutgers
University, Piscataway, New Jersey 088552
Received 21 December 1999/Accepted 18 April 2000
The E6 protein of the high-risk human papillomaviruses (HPVs) and
the cellular ubiquitin-protein ligase E6AP form a complex which causes
the ubiquitination and degradation of p53. We show here that HPV16 E6
promotes the ubiquitination and degradation of E6AP itself. The
half-life of E6AP is shorter in HPV-positive cervical cancer cells than
in HPV-negative cervical cancer cells, and E6AP is stabilized in
HPV-positive cancer cells when expression of the viral oncoproteins is
repressed. Expression of HPV16 E6 in cells results in a threefold
decrease in the half-life of transfected E6AP. E6-mediated degradation
of E6AP requires (i) the binding of E6 to E6AP, (ii) the catalytic
activity of E6AP, and (iii) activity of the 26S proteasome, suggesting
that E6-E6AP interaction results in E6AP self-ubiquitination and
degradation. In addition, both in vitro and in vivo experiments
indicate that E6AP self-ubiquitination results primarily from an
intramolecular transfer of ubiquitin from the active-site cysteine to
one or more lysine residues; however, intermolecular transfer can also
occur in the context of an E6-mediated E6AP multimer. Finally, we
demonstrate that an E6 mutant that is able to immortalize human mammary
epithelial cells but is unable to degrade p53 retains its ability to
bind and degrade E6AP, raising the possibility that E6-mediated
degradation of E6AP contributes to its ability to transform mammalian cells.
*
Corresponding author. Mailing address for Jon M. Huibregtse: Department of Molecular Biology and Biochemistry, Rutgers
University, Piscataway, NJ 08855. Phone: (732) 445-0938. Fax: (732)
445-4213. E-mail: huibregt{at}waksman.rutgers.edu. Mailing
address for Peter M. Howley: Department of Pathology, Harvard Medical
School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-2884. Fax: (617) 432-2882. E-mail:
peter_howley{at}hms.harvard.edu.
Journal of Virology, July 2000, p. 6408-6417, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bedard, K. M., Underbrink, M. P., Howie, H. L., Galloway, D. A.
(2008). The E6 Oncoproteins from Human Betapapillomaviruses Differentially Activate Telomerase through an E6AP-Dependent Mechanism and Prolong the Lifespan of Primary Keratinocytes. J. Virol.
82: 3894-3902
[Abstract]
[Full Text]
-
Sekaric, P., Cherry, J. J., Androphy, E. J.
(2008). Binding of Human Papillomavirus Type 16 E6 to E6AP Is Not Required for Activation of hTERT. J. Virol.
82: 71-76
[Abstract]
[Full Text]
-
Storrs, C. H., Silverstein, S. J.
(2007). PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6. J. Virol.
81: 4080-4090
[Abstract]
[Full Text]
-
Shirakura, M., Murakami, K., Ichimura, T., Suzuki, R., Shimoji, T., Fukuda, K., Abe, K., Sato, S., Fukasawa, M., Yamakawa, Y., Nishijima, M., Moriishi, K., Matsuura, Y., Wakita, T., Suzuki, T., Howley, P. M., Miyamura, T., Shoji, I.
(2007). E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein. J. Virol.
81: 1174-1185
[Abstract]
[Full Text]
-
Handa, K., Yugawa, T., Narisawa-Saito, M., Ohno, S.-i., Fujita, M., Kiyono, T.
(2007). E6AP-Dependent Degradation of DLG4/PSD95 by High-Risk Human Papillomavirus Type 18 E6 Protein. J. Virol.
81: 1379-1389
[Abstract]
[Full Text]
-
Mani, A., Oh, A. S., Bowden, E. T., Lahusen, T., Lorick, K. L., Weissman, A. M., Schlegel, R., Wellstein, A., Riegel, A. T.
(2006). E6AP Mediates Regulated Proteasomal Degradation of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 in Immortalized Cells.. Cancer Res.
66: 8680-8686
[Abstract]
[Full Text]
-
Wei, Q.
(2005). Pitx2a Binds to Human Papillomavirus Type 18 E6 Protein and Inhibits E6-mediated P53 Degradation in HeLa Cells. J. Biol. Chem.
280: 37790-37797
[Abstract]
[Full Text]
-
Hengstermann, A., D'silva, M. A., Kuballa, P., Butz, K., Hoppe-Seyler, F., Scheffner, M.
(2005). Growth Suppression Induced by Downregulation of E6-AP Expression in Human Papillomavirus-Positive Cancer Cell Lines Depends on p53. J. Virol.
79: 9296-9300
[Abstract]
[Full Text]
-
Routes, J. M., Morris, K., Ellison, M. C., Ryan, S.
(2005). Macrophages Kill Human Papillomavirus Type 16 E6-Expressing Tumor Cells by Tumor Necrosis Factor Alpha- and Nitric Oxide-Dependent Mechanisms. J. Virol.
79: 116-123
[Abstract]
[Full Text]
-
Cooper, E. M., Hudson, A. W., Amos, J., Wagstaff, J., Howley, P. M.
(2004). Biochemical Analysis of Angelman Syndrome-associated Mutations in the E3 Ubiquitin Ligase E6-associated Protein. J. Biol. Chem.
279: 41208-41217
[Abstract]
[Full Text]
-
Longworth, M. S., Laimins, L. A.
(2004). Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev.
68: 362-372
[Abstract]
[Full Text]
-
Stewart, D., Kazemi, S., Li, S., Massimi, P., Banks, L., Koromilas, A. E., Matlashewski, G.
(2004). Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J. Gen. Virol.
85: 1419-1426
[Abstract]
[Full Text]
-
Nguyen, M., Song, S., Liem, A., Androphy, E., Liu, Y., Lambert, P. F.
(2002). A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding {alpha}-Helix Partners Displays Reduced Oncogenic Potential In Vivo. J. Virol.
76: 13039-13048
[Abstract]
[Full Text]
-
Klapisz, E., Sorokina, I., Lemeer, S., Pijnenburg, M., Verkleij, A. J., van Bergen en Henegouwen, P. M. P.
(2002). A Ubiquitin-interacting Motif (UIM) Is Essential for Eps15 and Eps15R Ubiquitination. J. Biol. Chem.
277: 30746-30753
[Abstract]
[Full Text]
-
Lossie, A C, Whitney, M M, Amidon, D, Dong, H J, Chen, P, Theriaque, D, Hutson, A, Nicholls, R D, Zori, R T, Williams, C A, Driscoll, D J
(2001). Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J. Med. Genet.
38: 834-845
[Abstract]
[Full Text]
-
Gaitonde, S. V., Qi, W., Falsey, R. R., Sidell, N., Martinez, J. D.
(2001). Morphologic Conversion of a Neuroblastoma-derived Cell Line by E6-mediated p53 Degradation. Cell Growth Differ.
12: 19-27
[Abstract]
[Full Text]
-
Nakagawa, S., Huibregtse, J. M.
(2000). Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase. Mol. Cell. Biol.
20: 8244-8253
[Abstract]
[Full Text]
-
Lai, Z., Ferry, K. V., Diamond, M. A., Wee, K. E., Kim, Y. B., Ma, J., Yang, T., Benfield, P. A., Copeland, R. A., Auger, K. R.
(2001). Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization. J. Biol. Chem.
276: 31357-31367
[Abstract]
[Full Text]
-
You, J., Pickart, C. M.
(2001). A HECT Domain E3 Enzyme Assembles Novel Polyubiquitin Chains. J. Biol. Chem.
276: 19871-19878
[Abstract]
[Full Text]
-
Gangappa, S., van Dyk, L. F., Jewett, T. J., Speck, S. H., Virgin, H. W. IV
(2002). Identification of the In Vivo Role of a Viral bcl-2. JEM
195: 931-940
[Abstract]
[Full Text]